Riskpilot← Back to searchSign inGet full accessMeliva Vårdcentral Lill-Jans AB
ABActiveOrg 5566201652Engelbrektsgatan 18General medical practice activities · NACE 8621Est. 200122 employees
Revenue 2025
SEK 30,8M
+207% vs 2024
EBITDA margin
-5.9%
-39% vs 2024
Equity ratio
24.0%
Financial strength
Net profit 2025
SEK -61K
+56% vs 2024
| Revenue | SEK 30,8M | +207% |
| EBITDA | SEK -1,8M | -39% |
| Net profit | SEK -61K | +56% |
| Total assets | SEK 8,4M | -6% |
| Equity | SEK 2M | -3% |
| Employees | 22 | — |
Legal name
Meliva Vårdcentral Lill-Jans AB
Org number
5566201652
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
19 december 2001
Share capital
SEK 100 000
Employees
22 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas var för sig av Schmidt, Matti Artturi Soininen, Herkko Samppa Westerholm, Anders Peter Mikael
Company purpose
Föremålet för bolagets verksamhet är hälso- och sjukvård, konsultverksamhet inom hälso- och sjukvård och därmed förenlig verksamhet.
Address
Engelbrektsgatan 18
Phone
+46854527290
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 28 072 | 28 394 | 30 297 | 10 032 | 30 751 |
| Staff expenses | −16 751 | −18 740 | — | −8 626 | — |
| EBITDA | 3 486 | 2 360 | 2 437 | −1 311 | −1 817 |
| Depreciation & amort. | −348 | −140 | −136 | −90 | −122 |
| EBIT | 3 138 | 2 220 | 2 301 | −1 401 | −1 939 |
| Net financials | −21 | −5 | 107 | 4 | 33 |
| Profit before tax | 2 879 | 2 156 | 2 182 | −140 | −61 |
| Tax | −570 | −471 | −482 | — | −0 |
| Net profit | 2 309 | 1 685 | 1 700 | −140 | −61 |
| Item | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 11 218 | 7 920 | 8 722 | 8 884 | 8 361 |
| Equity | 2 817 | 2 192 | 2 207 | 2 068 | 2 007 |
| Long-term debt | 0 | — | 0 | — | 0 |
| Short-term debt | 5 055 | 2 357 | 2 918 | 4 477 | 4 015 |
| Total debt | 5 055 | 2 357 | 2 918 | 4 477 | 4 015 |
EBITDA margin
-5.9%
This company
15.8%
Market median
-137% vs market
20222025
Equity ratio
24.0%
This company
38.2%
Market median
-37% vs market
20222025
Return on equity
-3.0%
This company
18.4%
Market median
-116% vs market
20222025
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20222025
Asset turnover
3.68×
This company
1.12×
Market median
+229% vs market
20222025
Debt / equity
3.17×
This company
0.62×
Market median
-411% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-09-01 – 2024-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JJ Chief Auditor | Chief Auditor | 2025 |
MA External Signatory | External Signatory | 2024 |
AP Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (3) | ||
ME Auditor Substitute | Auditor Substitute | 2021 – 2024 |
DM Audit | Audit | 2021 – 2024 |
JO Chief Auditor | Chief Auditor | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (6) | ||
| Board of Directors | 2022 – 2024 | |
| Chairman | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2024 | |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEHILÄINEN OY
Meliva Vårdcentral Lill-Jans AB Board members of Meliva Vårdcentral Lill-Jans AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Joakim Holmquist | Chief Auditor | 0 companies |
| Martin Emanuel Feldtenborn | Auditor Substitute | 0 companies |
| Matti Artturi Schmidt | External Signatory | 0 companies |
| Anders Peter Mikael Westerholm | Chief Executive Officer | 0 companies |
| Dusica Milic | Audit | 0 companies |
| Jens Oscar Simon Bertling | Chief Auditor | 0 companies |
| Sara Maria Birgitta Holzapfel | Board of Directors | 0 companies |
| Anna Katarina Reuterwall | Chairman | 0 companies |
| Maria Noel Mones Camara | Board of Directors | 0 companies |
| Sami Jukka Petteri Koski | Board of Directors | 0 companies |
| Ulrika Anna Karin Åberg Carlsson | Chairman | 0 companies |
| Anna Fredrika Mathilda Haeggström | Board of Directors | 0 companies |
| Herkko Sampa Soininen | Chairman | 0 companies |
| Markku Eero Antero Näreneva | Board of Directors | 0 companies |
| Kit Anette Melgaard | Board of Directors | 0 companies |